» Articles » PMID: 38622408

Targeting Aging and Age-related Diseases with Vaccines

Overview
Journal Nat Aging
Specialty Geriatrics
Date 2024 Apr 15
PMID 38622408
Authors
Affiliations
Soon will be listed here.
Abstract

Aging is a major risk factor for numerous chronic diseases. Vaccination offers a promising strategy to combat these age-related diseases by targeting specific antigens and inducing immune responses. Here, we provide a comprehensive overview of recent advances in vaccine-based interventions targeting these diseases, including Alzheimer's disease, type II diabetes, hypertension, abdominal aortic aneurysm, atherosclerosis, osteoarthritis, fibrosis and cancer, summarizing current approaches for identifying disease-associated antigens and inducing immune responses against these targets. Further, we reflect on the recent development of vaccines targeting senescent cells, as a strategy for more broadly targeting underlying causes of aging and associated pathologies. In addition to highlighting recent progress in these areas, we discuss important next steps to advance the therapeutic potential of these vaccines, including improving and robustly demonstrating efficacy in human clinical trials, as well as rigorously evaluating the safety and long-term effects of these vaccine strategies.

Citing Articles

Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders.

Sivalingam A Clin Rev Allergy Immunol. 2025; 68(1):14.

PMID: 39932617 DOI: 10.1007/s12016-025-09022-9.


Shared signaling pathways and comprehensive therapeutic approaches among diabetes complications.

Ebrahimi M, Ahmadieh H, Kanavi M, Safi S, Alipour-Parsa S, Advani S Front Med (Lausanne). 2025; 11:1497750.

PMID: 39845838 PMC: 11750824. DOI: 10.3389/fmed.2024.1497750.


Senolytic Vaccines from the Central and Peripheral Tolerance Perspective.

Vasilieva M, Shatalova R, Matveeva K, Shindyapin V, Minskaia E, Ivanov R Vaccines (Basel). 2025; 12(12.

PMID: 39772050 PMC: 11680330. DOI: 10.3390/vaccines12121389.


Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual-Targeting BMI1 for Senescence Induction and CSN5 for PD-L1 Degradation.

Hu H, Wang Q, Yu D, Tao X, Guo M, Tian S Adv Sci (Weinh). 2024; 12(7):e2413122.

PMID: 39721027 PMC: 11831439. DOI: 10.1002/advs.202413122.


Immune Alterations with Aging: Mechanisms and Intervention Strategies.

Yu W, Yu Y, Sun S, Lu C, Zhai J, Lei Y Nutrients. 2024; 16(22).

PMID: 39599617 PMC: 11597283. DOI: 10.3390/nu16223830.


References
1.
Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . Hallmarks of aging: An expanding universe. Cell. 2023; 186(2):243-278. DOI: 10.1016/j.cell.2022.11.001. View

2.
Benz C, Yau C . Ageing, oxidative stress and cancer: paradigms in parallax. Nat Rev Cancer. 2008; 8(11):875-9. PMC: 2603471. DOI: 10.1038/nrc2522. View

3.
Wu Z, Qu J, Zhang W, Liu G . Stress, epigenetics, and aging: Unraveling the intricate crosstalk. Mol Cell. 2023; 84(1):34-54. DOI: 10.1016/j.molcel.2023.10.006. View

4.
Cai Y, Song W, Li J, Jing Y, Liang C, Zhang L . The landscape of aging. Sci China Life Sci. 2022; 65(12):2354-2454. PMC: 9446657. DOI: 10.1007/s11427-022-2161-3. View

5.
Dehghan A, van Hoek M, Sijbrands E, Stijnen T, Hofman A, Witteman J . Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care. 2007; 30(10):2695-9. DOI: 10.2337/dc07-0348. View